Fig. 4.  Glibenclamide (Glib), but not iberiotoxin (Iberi), blocks the dilation effects of cromakalim and calcitonin gene–related polypeptide (CGRP). Iberiotoxin, but not glibenclamide, blocks the dilation effects of NS1619 (n = 5). (A ) Effects of 10 nM cromakalim, CGRP, and NS1619, in the presence versus  absence of pretreatment agents. (B ) Effects of 1 μM cromakalim, CGRP, and NS1619. * First-administered agent.

Fig. 4.  Glibenclamide (Glib), but not iberiotoxin (Iberi), blocks the dilation effects of cromakalim and calcitonin gene–related polypeptide (CGRP). Iberiotoxin, but not glibenclamide, blocks the dilation effects of NS1619 (n = 5). (A ) Effects of 10 nM cromakalim, CGRP, and NS1619, in the presence versus  absence of pretreatment agents. (B ) Effects of 1 μM cromakalim, CGRP, and NS1619. * First-administered agent.

Close Modal

or Create an Account

Close Modal
Close Modal